Position statement on the use of biosimilars in inflammatory bowel disease. Swiss Med Wkly [Internet]. 2019 Dec. 2 [cited 2026 Jan. 22];149(4950):w20148. Available from: https://www.smw.ch/index.php/smw/article/view/2696